Publications

Cell Metabolism

April 12, 2016

Cell Stem Cell

January 3, 2013

Advanced Science

December 15. 2023

Advanced Healthcare Materials

October 28, 2024

Circulation

April 26, 2024

STEM CELL REPORTS

October 10, 2023

nature methods

November 29, 2009

iScience

September 25, 2020

iScience

November 15, 2024

Cell Stem Cell

July 02, 2010

Cell Reports Methods

December 18, 2023

Circulation Research

May 12, 2017

Cell Stem Cell

September 06, 2018

iScience

February 19, 2021

English

2014

A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes.

Natsuko Hemmi, Shugo Tohyama, Kazuaki Nakajima, Hideaki Kanazawa, Tomoyuki Suzuki, Fumiyuki Hattori, Tomohisa Seki, Yoshikazu Kishino, Akinori Hirano, Marina Okada, Ryota Tabei, Rei Ohno, Chihana Fujita, Tomoko Haruna, Shinsuke Yuasa, Motoaki Sano, Jun Fujita, Keiichi Fukuda

Stem cells translational medicine 3(12) 1473-83, December 2014

MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures.

Naoto Muraoka, Hiroyuki Yamakawa, Kazutaka Miyamoto, Taketaro Sadahiro, Tomohiko Umei, Mari Isomi, Hanae Nakashima, Mizuha Akiyama, Rie Wada, Kohei Inagawa, Takahiko Nishiyama, Ruri Kaneda, Toru Fukuda, Shu Takeda, Shugo Tohyama, Hisayuki Hashimoto, Yoshifumi Kawamura, Naoki Goshima, Ryo Aeba, Hiroyuki Yamagishi, Keiichi Fukuda, Masaki Ieda

The EMBO journal 33(14) 1565-81, 17 July 2014

Time-lapse imaging of cell cycle dynamics during development in living cardiomyocyte.

Hisayuki Hashimoto, Shinsuke Yuasa, Hidenori Tabata, Shugo Tohyama, Nozomi Hayashiji, Fumiyuki Hattori, Naoto Muraoka, Toru Egashira, Shinichiro Okata, Kojiro Yae, Tomohisa Seki, Takahiko Nishiyama, Kazunori Nakajima, Asako Sakaue-Sawano, Atsushi Miyawaki, Keiichi Fukuda

Journal of molecular and cellular cardiology 72 241-9 , July 2014

Endogenous prostaglandin D2 and its metabolites protect the heart against ischemia-reperfusion injury by activating Nrf2.

Yoshinori Katsumata, Ken Shinmura, Yuki Sugiura, Shugo Tohyama, Tomohiro Matsuhashi, Hideyuki Ito, Xiaoxiang Yan, Kentaro Ito, Shinsuke Yuasa, Masaki Ieda, Yoshihiro Urade, Makoto Suematsu, Keiichi Fukuda, Motoaki Sano

Hypertension (Dallas, Tex. : 1979) 63(1) 80-7, January 2014

Generation and characterization of functional cardiomyocytes derived from human T cell-derived induced pluripotent stem cells.

Tomohisa Seki, Shinsuke Yuasa, Dai Kusumoto, Akira Kunitomi, Yuki Saito, Shugo Tohyama, Kojiro Yae, Yoshikazu Kishino, Marina Okada, Hisayuki Hashimoto, Makoto Takei, Toru Egashira, Masaki Kodaira, Yusuke Kuroda, Atsushi Tanaka, Shinichiro Okata, Tomoyuki Suzuki, Mitsushige Murata, Jun Fujita, Keiichi Fukuda

PloS one 9(1) e85645, 2014

Derivation of transgene-free human induced pluripotent stem cells from human peripheral T cells in defined culture conditions.

Yoshikazu Kishino, Tomohisa Seki, Jun Fujita, Shinsuke Yuasa, Shugo Tohyama, Akira Kunitomi, Ryota Tabei, Kazuaki Nakajima, Marina Okada, Akinori Hirano, Hideaki Kanazawa, Keiichi Fukuda

PloS one 9(5) e97397, 2014

Japanese

2014

Publications

English

A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes.

MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures.

Time-lapse imaging of cell cycle dynamics during development in living cardiomyocyte.

Endogenous prostaglandin D2 and its metabolites protect the heart against ischemia-reperfusion injury by activating Nrf2.

Generation and characterization of functional cardiomyocytes derived from human T cell-derived induced pluripotent stem cells.

Derivation of transgene-free human induced pluripotent stem cells from human peripheral T cells in defined culture conditions.

Japanese

心臓再生医療で乗り越えなければならないハードルとは―心臓再生医療における現状と課題

心臓再生医療で乗り越えなければならないハードルとは-心臓再生医療における現状と課題

ゼラチンハイドロゲルを使用した,不全心に対する心筋細胞移植による急性期機能改善と移植効率の検討

代謝的アプローチによるESおよびiPS細胞における未分化幹細胞除去法および心筋精製法

発生学・再生学シリーズ網羅的代謝解析の再生医学への応用

心臓移植治療の現在